High expression of cathepsin B and plasminogen activator inhibitor type-1 are strong predictors of survival in glioblastomas.
about
A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma CareAssociation of matrix metalloproteinase 2 plasma level with response and survival in patients treated with bevacizumab for recurrent high-grade glioma.Expression of the lysosomal-associated membrane protein-1 (LAMP-1) in astrocytomasExpression Analysis of All Protease Genes Reveals Cathepsin K to Be Overexpressed in GlioblastomaThe development of MDA-7/IL-24 as a cancer therapeuticCUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide.Methylation profiling identifies 2 groups of gliomas according to their tumorigenesisGlioma-derived plasminogen activator inhibitor-1 (PAI-1) regulates the recruitment of LRP1 positive mast cells.Molecular alterations in glioblastoma: potential targets for immunotherapy.End-binding 1 protein overexpression correlates with glioblastoma progression and sensitizes to Vinca-alkaloids in vitro and in vivo.Hypoxia enhances the antiglioma cytotoxicity of B10, a glycosylated derivative of betulinic acidCD133/prominin1 is prognostic for GBM patient's survival, but inversely correlated with cysteine cathepsins' expression in glioblastoma derived spheroidsIGFBP-4 anti-angiogenic and anti-tumorigenic effects are associated with anti-cathepsin B activity.Blockade of vascular endothelial growth factor receptors by tivozanib has potential anti-tumour effects on human glioblastoma cellsLong-term epilepsy-associated tumors.Predictors of long-term survival in patients with glioblastoma multiforme: advancements from the last quarter century.Systematic review of protein biomarkers of invasive behavior in glioblastoma.Glioblastoma complicated by fatal malignant acute ischemic stroke: MRI finding to assist in tricky surgical decision.Interleukin-1-induced changes in the glioblastoma secretome suggest its role in tumor progression.The influence of SRPK1 on glioma apoptosis, metastasis, and angiogenesis through the PI3K/Akt signaling pathway under normoxia.Synthesis and radiopharmacological characterisation of a fluorine-18-labelled azadipeptide nitrile as a potential PET tracer for in vivo imaging of cysteine cathepsins.The regulation of cysteine cathepsins and cystatins in human gliomas.Prothrombotic state in glioblastoma multiforme: an evaluation of the procoagulant activity of circulating microparticles.Genomic profiling reveals distinctive molecular relapse patterns in IDH1/2 wild-type glioblastoma.
P2860
Q26851160-F5EB800D-BD76-4E08-9420-06FACA3F8E98Q27852713-835F4EE1-998C-4497-9DAC-541FF8FB3209Q28293914-7BCC5438-AED1-44CE-ACF0-02B60BDD4DB3Q29302290-036C5561-BCEA-40BB-805D-8B51A15AE884Q34163896-182D0C1B-30F6-411C-A89A-55558029FD19Q34437996-DAD01F96-FA7C-4967-9C53-BF1D499129F1Q34480513-90CC6376-048B-4FC2-B8C4-62C944EC28AFQ34484456-22630C8F-6913-4900-BF88-98F127827DD1Q34870511-B4ECD46B-B6F2-43D5-BA8C-9D3D3A90AA30Q35149672-31650039-334C-46CD-9EBB-9D0F98FEB03BQ35152103-49568D52-29B6-483F-9E2A-2752619D4FD4Q36177768-5595E2AF-0DFD-489B-BB2F-5283802EA8E0Q36801110-576A5DCF-0BAC-4DD3-A0CD-39BC64FD97A7Q37695245-66C9057D-DB10-4063-93BE-6F5F2CBDFEA0Q38002123-5BCE05E4-51A9-4F0A-865D-8E21D3003C53Q38101368-EAEEE70F-AFFE-4F54-B14D-C323AA86540DQ38165795-B67ACCD7-633D-4056-89FB-5ACDFB85FB90Q38535581-E471CAEB-3A6A-4CC6-B310-931201DBE777Q38637324-2B33E899-79A7-4128-ABCE-6E56CE92CCD2Q38891990-2F8E886A-48D9-4BE0-A9ED-6E0C25CC0267Q39137404-604A4909-FE8D-4052-82F4-672D7F1F95DEQ48686047-839447EB-C78F-4E6D-ADDD-C59454813E68Q53781843-A38FAC00-1268-44B3-8910-2FF844C7BD0EQ55461027-D4409351-E7D5-40CD-AC18-242A75721398
P2860
High expression of cathepsin B and plasminogen activator inhibitor type-1 are strong predictors of survival in glioblastomas.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
High expression of cathepsin B ...... of survival in glioblastomas.
@en
High expression of cathepsin B ...... of survival in glioblastomas.
@nl
type
label
High expression of cathepsin B ...... of survival in glioblastomas.
@en
High expression of cathepsin B ...... of survival in glioblastomas.
@nl
prefLabel
High expression of cathepsin B ...... of survival in glioblastomas.
@en
High expression of cathepsin B ...... of survival in glioblastomas.
@nl
P2093
P1476
High expression of cathepsin B ...... of survival in glioblastomas.
@en
P2093
Anderson Loundou
Brigitte Voutsinos-Porche
Carole Colin
Christine Delfino
Corinne Bouvier
Dominique Intagliata
Frédéric Fina
Isabelle Nanni
L'Houcine Ouafik
P2888
P304
P356
10.1007/S00401-009-0592-2
P577
2009-09-23T00:00:00Z